Rovee-Bhalla

Buy Sun Pharma for approx. 14% gain ( Target 600 )

Long
Rovee-Bhalla Updated   
NSE:SUNPHARMA   SUN PHARMACEUTICAL
1.Sun Pharma broke above its 200 DMA and tested it back again on weekly chart.

2. It has broken out of two consolidations:
a. Long term consolidation from 2019
b. short term consolidation from April 2020

TARGET : 600
C.P : 525
STOP LOSS: 515



Trade closed: stop reached:
STOPPED OUT
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.